Cargando…
Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication
Collagens in the extracellular matrix (ECM) provide a physical barrier to tumor immune infiltration, while also acting as a ligand for immune inhibitory receptors. Transforming growth factor-β (TGF-β) is a key contributor to shaping the ECM by stimulating the production and remodeling of collagens....
Autores principales: | Horn, Lucas A., Chariou, Paul L., Gameiro, Sofia R., Qin, Haiyan, Iida, Masafumi, Fousek, Kristen, Meyer, Thomas J., Cam, Margaret, Flies, Dallas, Langermann, Solomon, Schlom, Jeffrey, Palena, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012291/ https://www.ncbi.nlm.nih.gov/pubmed/35230974 http://dx.doi.org/10.1172/JCI155148 |
Ejemplares similares
-
Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies
por: Minnar, Christine M, et al.
Publicado: (2022) -
Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
por: Flies, Dallas B., et al.
Publicado: (2023) -
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction
por: Ramos, M Ines Pascoal, et al.
Publicado: (2021) -
LAIR-1 agonism as a therapy for acute myeloid leukemia
por: Lovewell, Rustin R., et al.
Publicado: (2023) -
Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity
por: Horn, Lucas A, et al.
Publicado: (2020)